Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Current Leases (2016 - 2025)

Historic Current Leases for Lineage Cell Therapeutics (LCTX) over the last 12 years, with Q3 2025 value amounting to $1.0 million.

  • Lineage Cell Therapeutics' Current Leases fell 554.02% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 554.02%. This contributed to the annual value of $1.1 million for FY2024, which is 3216.87% up from last year.
  • As of Q3 2025, Lineage Cell Therapeutics' Current Leases stood at $1.0 million, which was down 554.02% from $998000.0 recorded in Q2 2025.
  • Lineage Cell Therapeutics' 5-year Current Leases high stood at $1.1 million for Q1 2025, and its period low was $543000.0 during Q3 2022.
  • In the last 5 years, Lineage Cell Therapeutics' Current Leases had a median value of $912000.0 in 2023 and averaged $892157.9.
  • The largest annual percentage gain for Lineage Cell Therapeutics' Current Leases in the last 5 years was 6413.93% (2021), contrasted with its biggest fall of 3661.29% (2021).
  • Over the past 5 years, Lineage Cell Therapeutics' Current Leases (Quarter) stood at $801000.0 in 2021, then increased by 14.36% to $916000.0 in 2022, then decreased by 9.39% to $830000.0 in 2023, then soared by 32.17% to $1.1 million in 2024, then dropped by 6.75% to $1.0 million in 2025.
  • Its Current Leases stands at $1.0 million for Q3 2025, versus $998000.0 for Q2 2025 and $1.1 million for Q1 2025.